Arrowhead Pharmaceuticals Ownership | Who Owns Arrowhead Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Arrowhead Pharmaceuticals Ownership Summary


Arrowhead Pharmaceuticals is owned by 84.30% institutional investors, 3.67% insiders, and 12.03% retail investors. Blackrock is the largest institutional shareholder, holding 12.72% of ARWR shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.41% of its assets in Arrowhead Pharmaceuticals shares.

ARWR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockArrowhead Pharmaceuticals84.30%3.67%12.03%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock15.68M12.72%$407.61M
Vanguard group15.29M11.27%$1.02B
Blackrock funding, inc. /de14.83M10.41%$1.21B
Avoro capital advisors11.36M7.97%$925.59M
Fmr8.04M5.65%$655.32M
Vanguard capital management6.11M4.29%$498.10M
State street5.69M4.00%$464.17M
Norges bank3.90M2.74%$317.61M
Invesco3.88M2.73%$316.58M
Geode capital management3.53M2.48%$298.81M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aquilo capital management707.59K20.06%$13.30M
Western financial corp/ca820.24K19.58%$66.86M
Avoro capital advisors11.36M8.31%$925.59M
M28 capital management lp36.85K6.37%$3.00M
Act capital management110.10K5.86%$8.97M
Privium fund management b.v.234.22K3.51%$19.09M
Wealth effects147.30K3.24%$12.01M
Vestal point capital, lp1.57M3.00%$128.38M
Siren1.72M2.83%$139.83M
Evolutionary tree capital management14.37K2.21%$1.17M

Top Buyers

HolderShares% AssetsChange
Norges bank3.90M0.03%3.90M
First trust advisors lp1.35M0.06%1.20M
Holocene advisors, lp1.11M0.20%1.11M
Sixth street partners management company923.93K0.01%923.93K
Fmr8.04M0.03%773.15K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de14.83M0.02%-3.33M
Slate path capital lp---2.52M
Rokos capital management llp---939.98K
T. rowe price investment management---822.34K
State street5.69M0.01%-801.49K

New Positions

HolderShares% AssetsChangeValue
Norges bank3.90M0.03%3.90M$317.61M
Holocene advisors, lp1.11M0.20%1.11M$90.16M
Sixth street partners management company923.93K0.01%923.93K$75.31M
1832 asset management538.50K0.02%538.50K$43.89M
Hrt financial lp498.65K0.07%498.65K$40.65M

Sold Out

HolderChange
Financial gravity asset management-4.00
Abound wealth management-8.00
National bank of canada /fi/-10.00
Innealta capital-11.00
Advisornet financial-12.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202651712.39%120,057,918-0.61%841.13%2780.36%16036.75%
Mar 31, 20264476.18%119,350,1862.88%851.24%2663.91%1165.45%
Dec 31, 2025134-57.32%23,726,403-78.62%170.27%82-51.19%34-58.54%
Sep 30, 2025128-57.19%25,567,183-75.82%180.32%64-58.97%30-62.50%
Jun 30, 20252936.55%105,554,9492.21%751.29%15119.84%79-2.47%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF7.47M5.41%-
iShares Core S&P Mid-Cap ETF4.84M3.43%149.00
Vanguard MStar Total Stk Mkt Idx Invest4.26M3.02%12.71K
Vanguard Total Stock Mkt Idx Inv4.25M3.02%12.94K
Vanguard Morn Total Stk Mkt Idx Investor4.25M3.02%12.94K
Vanguard US Total Market Shares ETF3.70M2.70%3.98K
iShares Russell 2000 ETF3.24M2.30%29.90K
Fidelity Growth Compy Commingled Pl S3.22M2.28%100.00K
Vanguard Small Cap Index3.08M2.18%6.51K
Fidelity Growth Company Fund2.43M1.72%71.70K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 18, 2026OLUKOTUN ADEOYE Y-Sell$173.92K
Aug 18, 2026PERRY MICHAEL S-Sell$1.01M
May 12, 2026Lu Hongbo-Sell$228.33K
Apr 22, 2026Apel Daniel Joseph Chief Financial OfficerSell$627.86K
Apr 22, 2026Apel Daniel Joseph Chief Financial OfficerSell$224.91K

Insider Transactions Trends


DateBuySell
2026 Q3-2
2026 Q2-5
2026 Q1-22
2025 Q4-36
2025 Q3-4

ARWR Ownership FAQ


Who Owns Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals shareholders are primarily institutional investors at 84.30%, followed by 3.67% insiders and 12.03% retail investors. The average institutional ownership in Arrowhead Pharmaceuticals's industry, Biotech Stocks , is 380.48%, which Arrowhead Pharmaceuticals falls below.

Who owns the most shares of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals’s largest shareholders are Blackrock (15.68M shares, 12.72%), Vanguard group (15.29M shares, 11.27%), and Blackrock funding, inc. /de (14.83M shares, 10.41%). Together, they hold 34.40% of Arrowhead Pharmaceuticals’s total shares outstanding.

Does Blackrock own Arrowhead Pharmaceuticals?

Yes, BlackRock owns 12.72% of Arrowhead Pharmaceuticals, totaling 15.68M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 407.61M$. In the last quarter, BlackRock increased its holdings by 336.57K shares, a 2.19% change.

Who is Arrowhead Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Aquilo capital management is Arrowhead Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 20.06% of its assets in 707.59K Arrowhead Pharmaceuticals shares, valued at 13.3M$.

Who is the top mutual fund holder of Arrowhead Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Arrowhead Pharmaceuticals shares, with 5.41% of its total shares outstanding invested in 7.47M Arrowhead Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools